SK Biopharmaceuticals Co., Ltd. (KRX: 326030)
South Korea
· Delayed Price · Currency is KRW
103,300
-200 (-0.19%)
Nov 15, 2024, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.93 trillion as of November 18, 2024. Its market cap has increased by 31.60% in one year.
Market Cap
7.93T
Enterprise Value
7.88T
Revenue
465.06B
Ranking
n/a
PE Ratio
234.74
Stock Price
103,300.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.93T, a decrease of -20.31%. That is a compound annual growth rate of -5.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 18, 2024 | 7,925.30B | 0.80% |
Dec 28, 2023 | 7,862.65B | 39.25% |
Dec 29, 2022 | 5,646.39B | -25.82% |
Dec 30, 2021 | 7,612.05B | -42.49% |
Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition